These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 21564329)
1. Factors impacting the combination of topical corticosteroid therapies for psoriasis: perspectives from the International Psoriasis Council. van de Kerkhof PC; Kragballe K; Segaert S; Lebwohl M; J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1130-9. PubMed ID: 21564329 [TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy and safety of tazarotene: optimizing clinical results. Lebwohl M Cutis; 1998 Feb; 61(2 Suppl):27-9. PubMed ID: 9787989 [TBL] [Abstract][Full Text] [Related]
5. Topical therapies for the treatment of localized plaque psoriasis in primary care: a cost-effectiveness analysis. Sawyer L; Samarasekera EJ; Wonderling D; Smith CH Br J Dermatol; 2013 May; 168(5):1095-105. PubMed ID: 23374249 [TBL] [Abstract][Full Text] [Related]
6. [Topical corticosteroids and corticosteroid sparing therapy in psoriasis management]. Sukarovska BG; Lipozencić J; Vrzogić P Acta Med Croatica; 2007 Sep; 61(4):375-81. PubMed ID: 18044472 [TBL] [Abstract][Full Text] [Related]
7. Current effective topical therapies in the management of psoriasis. Kurian A; Barankin B Skin Therapy Lett; 2011 Jan; 16(1):4-7. PubMed ID: 21293834 [TBL] [Abstract][Full Text] [Related]
8. Corticosteroids: options in the era of steroid-sparing therapy. Del Rosso J; Friedlander SF J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S50-8. PubMed ID: 15968264 [TBL] [Abstract][Full Text] [Related]
9. Are ointments better than other vehicles for corticosteroid treatment of psoriasis? Zivkovich AH; Feldman SR J Drugs Dermatol; 2009 Jun; 8(6):570-2. PubMed ID: 19537382 [TBL] [Abstract][Full Text] [Related]
10. An update on topical therapies for mild-moderate psoriasis. van de Kerkhof PC Dermatol Clin; 2015 Jan; 33(1):73-7. PubMed ID: 25412784 [TBL] [Abstract][Full Text] [Related]
11. NOVEL APPROACHES TO Topical Psoriasis Therapy. Koyama G; Liu J; Scaffidi A; Khazraee M; Epstein B Int J Pharm Compd; 2015; 19(5):357-65. PubMed ID: 26775441 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms of action of topical therapies and the rationale for combination therapy. Norris DA J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S17-25. PubMed ID: 15968260 [TBL] [Abstract][Full Text] [Related]
14. Topical treatment of psoriasis with corticosteroids. Maibach H Acta Derm Venereol Suppl (Stockh); 1984; 112():17-23. PubMed ID: 6596821 [No Abstract] [Full Text] [Related]
15. Management of scalp psoriasis: guidelines for corticosteroid use in combination treatment. van der Vleuten CJ; van de Kerkhof PC Drugs; 2001; 61(11):1593-8. PubMed ID: 11577796 [TBL] [Abstract][Full Text] [Related]
16. Pharmacoeconomic model of topical treatment options of mild to moderate psoriasis vulgaris in Germany. Augustin M; Radtke M; van Engen A; Ruedig C; Lapp C; Moehling U J Dtsch Dermatol Ges; 2009 Apr; 7(4):329-38. PubMed ID: 19243481 [TBL] [Abstract][Full Text] [Related]
17. New developments in topical sequential therapy for psoriasis. Koo JY Skin Therapy Lett; 2005 Nov; 10(9):1-4. PubMed ID: 16292458 [TBL] [Abstract][Full Text] [Related]